Pharmacologic treatments for covid-19 patients
vs
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=137
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04366089 PROBIOZOVID Araimo F , J Med Virol, 2020 Full text Commentary |
No specific funding |
Oxygen-Ozone+Probiotic |
Standard care |
RCT | Patients with confirmed COVID-19 (moderate-severe) admitted to a single center in Italy | N=28 |
High Details |
|